In breast cancer cells, FOXO3a displaces FOXM1 and recruits histone deacetylase 2 (HDAC2) to the VEGF promoter, leading to reduced histone acetylation and suppressed VEGF transcription [48]. This evidence concerns the gene VEGFA and breast carcinoma.